AHP Logo
Inspire2024-05-16T15:25:31-07:00

THOUGHT LEADERSHIP

The Inspire Blog

We created the Inspire blog to have a positive impact on both the health care system and its clients.

  • December 8, 2023

    This is a follow-up to a prior Inspire Blog article[1] we posted and the first of three we’ll be posting now that more information, detail, and realities have come to pass; this post delves deeper...

  • November 9, 2023

    Prehospital medicine/patient care is a newer profession still being defined and, in many ways, redefining its role in today’s healthcare system. Prehospital medical/EMS education is...

  • November 3, 2023

    In the ever-evolving landscape of healthcare, the terms "value-based reimbursement" and "value-based care" (VBC) have become buzzwords that signify a shift in how we approach...

  • September 13, 2023

    As we try to identify key causes of high US healthcare costs, the topic of variation, specifically variation in practice style, often emerges.  It is an accepted fact that in manufacturing quality...

  • August 18, 2023

    Unlike insurers whose plans must comply with strict metal tier and essential health benefit requirements, self-funded groups benefit from flexibility of plan design and offerings. However...

  • June 29, 2023

    A former colleague came across an article I wrote last year, 'My Recent Experience with Kaiser Health System' – Axene Health Partners, LLC.  After reading the article, she reached out to ask my thoughts...

  • June 24, 2023

    To achieve savings benefits from the coming wave of biosimilars, biosimilars must be adopted by prescribers, members, and payers (through their formulary strategies). While previous...

  • June 4, 2023

    As with many things in life, change is challenging, often undetected when it starts, many times mislabeled as an aberration, but always important. As John F. Kennedy once said...

  • June 1, 2023

    Once the first Humira biosimilar, Amjevita, launched in the United States in January, payers needed to begin making decisions about coverage not only for Amjevita but for all the other Humira...

Any views or opinions presented in these articles are solely those of the author and do not necessarily represent those of the company. AHP accepts no liability for the content of these articles, or for the consequences of any actions taken on the basis of the information provided unless that information is subsequently confirmed in writing.

Go to Top